Tower Research Capital »

Bolt Biotherapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4k 259 5.32
2025-06-30 $2.3k 395 5.77

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Bolt Biotherapeutics

Vivo Capital
Sofinnova Ventures
Pivotal bioVenture Partners Investment Advisor
Tang Capital Management
Nan Fung Group Holdings
Samsara BioCapital
Board of Trustees of The Leland Stanford Junior University
Vanguard Group
Pfizer
Renaissance Technologies
Geode Capital Management
Susquehanna International
Shay Capital
Squarepoint Ops
DRW Holdings

View all funds holding Bolt Biotherapeutics